GLP-1RA improves liver steatosis, fibrosis
Treatment with glucagon-like peptide-1 receptor agonists (GLP-1RA) leads to improvement in liver steatosis and fibrosis, results of a study have shown. GLP-1RA also provides benefits to metabolic syndrome by reducing body mass index (BMI), waist circumference (WC), and hyperlipidaemia.